$ARTC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARTHROCARE CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ARTHROCARE CORP. Get notifications about new insider transactions in ARTHROCARE CORP for free.
Page: < prev 1 2 3 4 5 6 7 ... 13 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 10 2014 | ARTC | ARTHROCARE CORP | WOLOSZKO JEAN | Chief Tech Officer ... | Sell | S | 46.50 | 7,270 | 338,055 | 46,193 | 53.5 K to 46.2 K (-13.60 %) |
Jan 10 2014 | ARTC | ARTHROCARE CORP | WOLOSZKO JEAN | Chief Tech Officer ... | Buy | M | 23.50 | 7,270 | 170,845 | 53,463 | 46.2 K to 53.5 K (+15.74 %) |
Jan 06 2014 | ARTC | ARTHROCARE CORP | PROTHRO BRUCE | Chief Regulatory Of ... | Option Exercise | M | 24.38 | 134 | 3,267 | 79,336 | |
Jan 06 2014 | ARTC | ARTHROCARE CORP | PROTHRO BRUCE | Chief Regulatory Of ... | Option Exercise | M | 24.38 | 2,055 | 50,101 | 79,470 | |
Jan 06 2014 | ARTC | ARTHROCARE CORP | PROTHRO BRUCE | Chief Regulatory Of ... | Option Exercise | M | 36.08 | 14,550 | 524,964 | 81,525 | |
Jan 06 2014 | ARTC | ARTHROCARE CORP | PROTHRO BRUCE | Chief Regulatory Of ... | Option Exercise | M | 36.08 | 2,771 | 99,978 | 96,075 | |
Jan 06 2014 | ARTC | ARTHROCARE CORP | PROTHRO BRUCE | Chief Regulatory Of ... | Sell | S | 40.00 | 134 | 5,360 | 39,421 | 39.6 K to 39.4 K (-0.34 %) |
Jan 06 2014 | ARTC | ARTHROCARE CORP | PROTHRO BRUCE | Chief Regulatory Of ... | Buy | M | 24.38 | 134 | 3,267 | 39,555 | 39.4 K to 39.6 K (+0.34 %) |
Jan 06 2014 | ARTC | ARTHROCARE CORP | PROTHRO BRUCE | Chief Regulatory Of ... | Sell | S | 40.00 | 2,055 | 82,200 | 39,421 | 41.5 K to 39.4 K (-4.95 %) |
Jan 06 2014 | ARTC | ARTHROCARE CORP | PROTHRO BRUCE | Chief Regulatory Of ... | Buy | M | 24.38 | 2,055 | 50,101 | 41,476 | 39.4 K to 41.5 K (+5.21 %) |
Jan 06 2014 | ARTC | ARTHROCARE CORP | PROTHRO BRUCE | Chief Regulatory Of ... | Sell | S | 39.73 | 2,771 | 110,086 | 39,421 | 42.2 K to 39.4 K (-6.57 %) |
Jan 06 2014 | ARTC | ARTHROCARE CORP | PROTHRO BRUCE | Chief Regulatory Of ... | Buy | M | 36.08 | 2,771 | 99,978 | 42,192 | 39.4 K to 42.2 K (+7.03 %) |
Jan 06 2014 | ARTC | ARTHROCARE CORP | PROTHRO BRUCE | Chief Regulatory Of ... | Sell | S | 39.34 | 1,207 | 47,488 | 39,421 | 40.6 K to 39.4 K (-2.97 %) |
Jan 06 2014 | ARTC | ARTHROCARE CORP | PROTHRO BRUCE | Chief Regulatory Of ... | Sell | D | 39.34 | 1,207 | 47,488 | 40,628 | 41.8 K to 40.6 K (-2.89 %) |
Jan 06 2014 | ARTC | ARTHROCARE CORP | PROTHRO BRUCE | Chief Regulatory Of ... | Buy | M | 36.08 | 14,550 | 524,964 | 41,835 | 27.3 K to 41.8 K (+53.33 %) |
Dec 20 2013 | ARTC | ARTHROCARE CORP | BOYAN BARBARA D | Director | Option Exercise | M | 27.11 | 10,000 | 271,100 | 40,000 | |
Dec 20 2013 | ARTC | ARTHROCARE CORP | BOYAN BARBARA D | Director | Sell | S | 40.00 | 10,000 | 400,000 | 24,525 | 34.5 K to 24.5 K (-28.96 %) |
Dec 20 2013 | ARTC | ARTHROCARE CORP | BOYAN BARBARA D | Director | Buy | M | 27.11 | 10,000 | 271,100 | 34,525 | 24.5 K to 34.5 K (+40.77 %) |
Dec 20 2013 | ARTC | ARTHROCARE CORP | WOLOSZKO JEAN | Chief Technology Of ... | Option Exercise | M | 23.50 | 4,657 | 109,440 | 109,324 | |
Dec 20 2013 | ARTC | ARTHROCARE CORP | WOLOSZKO JEAN | Chief Technology Of ... | Sell | S | 40.00 | 6,000 | 240,000 | 46,193 | 52.2 K to 46.2 K (-11.50 %) |
Dec 20 2013 | ARTC | ARTHROCARE CORP | WOLOSZKO JEAN | Chief Technology Of ... | Sell | S | 39.95 | 4,657 | 186,047 | 52,193 | 56.9 K to 52.2 K (-8.19 %) |
Dec 20 2013 | ARTC | ARTHROCARE CORP | WOLOSZKO JEAN | Chief Technology Of ... | Buy | M | 23.50 | 4,657 | 109,440 | 56,850 | 52.2 K to 56.9 K (+8.92 %) |
Dec 18 2013 | ARTC | ARTHROCARE CORP | PACEK JAMES L | Sr VP,Global Market ... | Option Exercise | M | 36.08 | 2,389 | 86,195 | 0 | |
Dec 18 2013 | ARTC | ARTHROCARE CORP | PACEK JAMES L | Sr VP,Global Market ... | Option Exercise | M | 36.08 | 2,771 | 99,978 | 0 | |
Dec 18 2013 | ARTC | ARTHROCARE CORP | PACEK JAMES L | Sr VP,Global Market ... | Sell | S | 39.00 | 2,771 | 108,069 | 26,412 | 29.2 K to 26.4 K (-9.50 %) |
Dec 18 2013 | ARTC | ARTHROCARE CORP | PACEK JAMES L | Sr VP,Global Market ... | Buy | M | 36.08 | 2,771 | 99,978 | 29,183 | 26.4 K to 29.2 K (+10.49 %) |
Dec 18 2013 | ARTC | ARTHROCARE CORP | PACEK JAMES L | Sr VP,Global Market ... | Sell | S | 39.00 | 178 | 6,942 | 26,412 | 26.6 K to 26.4 K (-0.67 %) |
Dec 18 2013 | ARTC | ARTHROCARE CORP | PACEK JAMES L | Sr VP,Global Market ... | Sell | D | 39.00 | 178 | 6,942 | 26,590 | 26.8 K to 26.6 K (-0.66 %) |
Dec 18 2013 | ARTC | ARTHROCARE CORP | PACEK JAMES L | Sr VP,Global Market ... | Buy | M | 36.08 | 2,389 | 86,195 | 26,768 | 24.4 K to 26.8 K (+9.80 %) |
Oct 31 2013 | ARTC | ARTHROCARE CORP | WOLOSZKO JEAN | Chief Technology Of ... | Sell | S | 37.95 | 1,342 | 50,929 | 52,193 | 53.5 K to 52.2 K (-2.51 %) |
Oct 08 2013 | ARTC | ARTHROCARE CORP | PACEK JAMES L | Sr VP, Strategic Bu ... | Sell | S | 34.48 | 2,500 | 86,200 | 24,379 | 26.9 K to 24.4 K (-9.30 %) |
Jun 21 2013 | ARTC | ARTHROCARE CORP | SCHAFFNER SCOTT | SVP & GM SPORTS MED ... | Option Exercise | A | 35.76 | 8,408 | 300,670 | 8,408 | |
Jun 21 2013 | ARTC | ARTHROCARE CORP | SCHAFFNER SCOTT | SVP & GM SPORTS MED ... | Option Exercise | A | 35.76 | 3,014 | 107,781 | 3,014 | |
Jun 21 2013 | ARTC | ARTHROCARE CORP | SCHAFFNER SCOTT | SVP & GM SPORTS MED ... | Grant | A | 0.00 | 7,545 | 8 | 22,214 | 14.7 K to 22.2 K (+51.43 %) |
Jun 21 2013 | ARTC | ARTHROCARE CORP | Newton Todd | SVP, CFO & COO | Option Exercise | A | 35.76 | 25,273 | 903,762 | 25,273 | |
Jun 21 2013 | ARTC | ARTHROCARE CORP | Newton Todd | SVP, CFO & COO | Option Exercise | A | 35.76 | 3,276 | 117,150 | 3,276 | |
Jun 21 2013 | ARTC | ARTHROCARE CORP | Newton Todd | SVP, CFO & COO | Grant | A | 0.00 | 9,426 | 9 | 46,885 | 37.5 K to 46.9 K (+25.16 %) |
Jun 21 2013 | ARTC | ARTHROCARE CORP | Rew Richard W. II | Senior VP & General ... | Option Exercise | A | 35.76 | 6,562 | 234,657 | 6,562 | |
Jun 21 2013 | ARTC | ARTHROCARE CORP | Rew Richard W. II | Senior VP & General ... | Option Exercise | A | 35.76 | 2,955 | 105,671 | 2,955 | |
Jun 21 2013 | ARTC | ARTHROCARE CORP | Rew Richard W. II | Senior VP & General ... | Grant | A | 0.00 | 5,081 | 5 | 32,347 | 27.3 K to 32.3 K (+18.63 %) |
Jun 21 2013 | ARTC | ARTHROCARE CORP | FITZGERALD DAVID | Board of Directors | Grant | A | 0.00 | 34,955 | 35 | 199,514 | 164.6 K to 199.5 K (+21.24 %) |
Jun 21 2013 | ARTC | ARTHROCARE CORP | PACEK JAMES L | Sr VP, Strategic Bu ... | Option Exercise | A | 35.76 | 6,633 | 237,196 | 6,633 | |
Jun 21 2013 | ARTC | ARTHROCARE CORP | PACEK JAMES L | Sr VP, Strategic Bu ... | Option Exercise | A | 35.76 | 2,884 | 103,132 | 2,884 | |
Jun 21 2013 | ARTC | ARTHROCARE CORP | PACEK JAMES L | Sr VP, Strategic Bu ... | Grant | A | 0.00 | 5,081 | 5 | 27,305 | 22.2 K to 27.3 K (+22.86 %) |
Jun 21 2013 | ARTC | ARTHROCARE CORP | PROTHRO BRUCE | Chief Regulatory Of ... | Option Exercise | A | 35.76 | 2,400 | 85,824 | 98,846 | |
Jun 21 2013 | ARTC | ARTHROCARE CORP | PROTHRO BRUCE | Chief Regulatory Of ... | Option Exercise | A | 35.76 | 5,213 | 186,417 | 96,446 | |
Jun 21 2013 | ARTC | ARTHROCARE CORP | PROTHRO BRUCE | Chief Regulatory Of ... | Sell | S | 36.00 | 2,512 | 90,432 | 27,285 | 29.8 K to 27.3 K (-8.43 %) |
Jun 21 2013 | ARTC | ARTHROCARE CORP | PROTHRO BRUCE | Chief Regulatory Of ... | Grant | A | 0.00 | 4,573 | 5 | 29,797 | 25.2 K to 29.8 K (+18.13 %) |
Jun 21 2013 | ARTC | ARTHROCARE CORP | WOLOSZKO JEAN | Chief Technical Off ... | Option Exercise | A | 35.76 | 2,790 | 99,770 | 116,771 | |
Jun 21 2013 | ARTC | ARTHROCARE CORP | WOLOSZKO JEAN | Chief Technical Off ... | Option Exercise | A | 35.76 | 7,680 | 274,637 | 113,981 | |
Jun 21 2013 | ARTC | ARTHROCARE CORP | WOLOSZKO JEAN | Chief Technical Off ... | Grant | A | 0.00 | 6,097 | 6 | 53,535 | 47.4 K to 53.5 K (+12.85 %) |
May 29 2013 | ARTC | ARTHROCARE CORP | LENDAU TORD | Director | Option Exercise | M | 16.10 | 15,000 | 241,500 | 0 | |
May 29 2013 | ARTC | ARTHROCARE CORP | LENDAU TORD | Director | Sell | S | 33.28 | 15,000 | 499,188 | 27,241 | 42.2 K to 27.2 K (-35.51 %) |
May 29 2013 | ARTC | ARTHROCARE CORP | LENDAU TORD | Director | Buy | M | 16.10 | 15,000 | 241,500 | 42,241 | 27.2 K to 42.2 K (+55.06 %) |
May 29 2013 | ARTC | ARTHROCARE CORP | WILSON PETER | Director | Option Exercise | M | 16.10 | 10,000 | 161,000 | 0 | |
May 29 2013 | ARTC | ARTHROCARE CORP | WILSON PETER | Director | Option Exercise | M | 16.10 | 5,000 | 80,500 | 10,000 | |
May 29 2013 | ARTC | ARTHROCARE CORP | WILSON PETER | Director | Sell | S | 33.36 | 10,000 | 333,649 | 50,848 | 60.8 K to 50.8 K (-16.43 %) |
May 29 2013 | ARTC | ARTHROCARE CORP | WILSON PETER | Director | Buy | M | 16.10 | 10,000 | 161,000 | 60,848 | 50.8 K to 60.8 K (+19.67 %) |
May 29 2013 | ARTC | ARTHROCARE CORP | WILSON PETER | Director | Buy | M | 16.10 | 5,000 | 80,500 | 50,848 | 45.8 K to 50.8 K (+10.91 %) |
May 24 2013 | ARTC | ARTHROCARE CORP | OEP AC Holdings, LLC | 10% Owner | Option Exercise | A | 0.00 | 6,600 | 0 | 6,600 | |
May 24 2013 | ARTC | ARTHROCARE CORP | BELINFANTI GREGORY | Director | Option Exercise | A | 0.00 | 3,300 | 0 | 3,300 | |
May 24 2013 | ARTC | ARTHROCARE CORP | Ahrens Christian | Director | Option Exercise | A | 0.00 | 3,300 | 0 | 3,300 | |
May 23 2013 | ARTC | ARTHROCARE CORP | WILSON PETER | Director | Grant | A | 0.00 | 3,300 | 3 | 45,848 | 42.5 K to 45.8 K (+7.76 %) |
May 23 2013 | ARTC | ARTHROCARE CORP | GEREMSKI TERRENCE E | Director | Grant | A | 0.00 | 3,300 | 3 | 24,454 | 21.2 K to 24.5 K (+15.60 %) |
May 23 2013 | ARTC | ARTHROCARE CORP | FOSTER JAMES | Director | Grant | A | 0.00 | 3,300 | 3 | 61,370 | 58.1 K to 61.4 K (+5.68 %) |
May 23 2013 | ARTC | ARTHROCARE CORP | BOYAN BARBARA D | Director | Grant | A | 0.00 | 3,300 | 3 | 24,525 | 21.2 K to 24.5 K (+15.55 %) |
May 23 2013 | ARTC | ARTHROCARE CORP | LENDAU TORD | Director | Grant | A | 0.00 | 3,300 | 3 | 27,241 | 23.9 K to 27.2 K (+13.78 %) |
Jan 09 2013 | ARTC | ARTHROCARE CORP | FOSTER JAMES G | Director | Sell | S | 35.05 | 10,500 | 367,994 | 58,070 | 68.6 K to 58.1 K (-15.31 %) |
Dec 31 2012 | ARTC | ARTHROCARE CORP | FOSTER JAMES G | Director | Option Exercise | M | 16.10 | 15,000 | 241,500 | 0 | |
Dec 31 2012 | ARTC | ARTHROCARE CORP | FOSTER JAMES G | Director | Buy | M | 16.10 | 15,000 | 241,500 | 68,570 | 53.6 K to 68.6 K (+28.00 %) |
Dec 31 2012 | ARTC | ARTHROCARE CORP | FOSTER JAMES G | Director | Buy | M | 16.10 | 15,000 | 241,500 | 53,570 | 38.6 K to 53.6 K (+38.89 %) |
Nov 15 2012 | ARTC | ARTHROCARE CORP | FITZGERALD DAVID | Board of Directors | Option Exercise | M | 13.29 | 25,000 | 332,250 | 0 | |
Nov 15 2012 | ARTC | ARTHROCARE CORP | FITZGERALD DAVID | Board of Directors | Option Exercise | M | 13.29 | 25,000 | 332,250 | 25,000 | |
Nov 15 2012 | ARTC | ARTHROCARE CORP | FITZGERALD DAVID | Board of Directors | Sell | S | 31.34 | 25,000 | 783,450 | 164,559 | 189.6 K to 164.6 K (-13.19 %) |
Nov 15 2012 | ARTC | ARTHROCARE CORP | FITZGERALD DAVID | Board of Directors | Buy | M | 13.29 | 25,000 | 332,250 | 189,559 | 164.6 K to 189.6 K (+15.19 %) |
Nov 15 2012 | ARTC | ARTHROCARE CORP | FITZGERALD DAVID | Board of Directors | Buy | M | 13.29 | 25,000 | 332,250 | 164,559 | 139.6 K to 164.6 K (+17.91 %) |
Aug 09 2012 | ARTC | ARTHROCARE CORP | FOSTER JAMES G | Director | Option Exercise | M | 13.05 | 35,000 | 456,750 | 0 | |
Aug 09 2012 | ARTC | ARTHROCARE CORP | FOSTER JAMES G | Director | Option Exercise | M | 13.05 | 15,000 | 195,750 | 35,000 | |
Aug 09 2012 | ARTC | ARTHROCARE CORP | FOSTER JAMES G | Director | Sell | S | 28.81 | 35,000 | 1,008,350 | 38,570 | 73.6 K to 38.6 K (-47.57 %) |
Aug 09 2012 | ARTC | ARTHROCARE CORP | FOSTER JAMES G | Director | Buy | M | 13.05 | 35,000 | 456,750 | 73,570 | 38.6 K to 73.6 K (+90.74 %) |
Aug 09 2012 | ARTC | ARTHROCARE CORP | FOSTER JAMES G | Director | Buy | M | 13.05 | 15,000 | 195,750 | 38,570 | 23.6 K to 38.6 K (+63.64 %) |
Jul 06 2012 | ARTC | ARTHROCARE CORP | PROTHRO BRUCE | Chief Regulatory Of ... | Sell | S | 30.00 | 1,768 | 53,040 | 27,606 | 29.4 K to 27.6 K (-6.02 %) |
Jul 06 2012 | ARTC | ARTHROCARE CORP | PROTHRO BRUCE | Chief Regulatory Of ... | Sell | S | 30.00 | 399 | 11,970 | 29,374 | 29.8 K to 29.4 K (-1.34 %) |
May 30 2012 | ARTC | ARTHROCARE CORP | WILSON PETER | Director | Option Exercise | M | 13.31 | 10,000 | 133,100 | 0 | |
May 30 2012 | ARTC | ARTHROCARE CORP | WILSON PETER | Director | Option Exercise | M | 13.31 | 5,000 | 66,550 | 10,000 | |
May 30 2012 | ARTC | ARTHROCARE CORP | WILSON PETER | Director | Sell | S | 26.68 | 10,000 | 266,800 | 42,548 | 52.5 K to 42.5 K (-19.03 %) |
May 30 2012 | ARTC | ARTHROCARE CORP | WILSON PETER | Director | Buy | M | 13.31 | 10,000 | 133,100 | 52,548 | 42.5 K to 52.5 K (+23.50 %) |
May 30 2012 | ARTC | ARTHROCARE CORP | WILSON PETER | Director | Buy | M | 13.31 | 5,000 | 66,550 | 42,548 | 37.5 K to 42.5 K (+13.32 %) |
May 30 2012 | ARTC | ARTHROCARE CORP | WILSON PETER | Director | Grant | A | 0.00 | 4,312 | 4 | 37,548 | 33.2 K to 37.5 K (+12.97 %) |
May 30 2012 | ARTC | ARTHROCARE CORP | GEREMSKI TERRENCE E | Director | Grant | A | 0.00 | 4,312 | 4 | 21,154 | 16.8 K to 21.2 K (+25.60 %) |
May 29 2012 | ARTC | ARTHROCARE CORP | BOYAN BARBARA D | Director | Grant | A | 0.00 | 4,312 | 4 | 21,225 | 16.9 K to 21.2 K (+25.50 %) |
May 29 2012 | ARTC | ARTHROCARE CORP | LENDAU TORD | Director | Option Exercise | M | 13.31 | 15,000 | 199,650 | 0 | |
May 29 2012 | ARTC | ARTHROCARE CORP | LENDAU TORD | Director | Sell | S | 26.13 | 15,000 | 391,950 | 23,941 | 38.9 K to 23.9 K (-38.52 %) |
May 29 2012 | ARTC | ARTHROCARE CORP | LENDAU TORD | Director | Buy | M | 13.31 | 15,000 | 199,650 | 38,941 | 23.9 K to 38.9 K (+62.65 %) |
May 29 2012 | ARTC | ARTHROCARE CORP | LENDAU TORD | Director | Grant | A | 0.00 | 4,312 | 4 | 23,941 | 19.6 K to 23.9 K (+21.97 %) |
May 29 2012 | ARTC | ARTHROCARE CORP | BELINFANTI GREGORY | Director | Option Exercise | A | 0.00 | 4,312 | 0 | 4,312 | |
May 29 2012 | ARTC | ARTHROCARE CORP | FOSTER JAMES G | Director | Grant | A | 0.00 | 4,312 | 4 | 23,570 | 19.3 K to 23.6 K (+22.39 %) |
May 29 2012 | ARTC | ARTHROCARE CORP | OEP AC Holdings, LLC | 10% Owner | Option Exercise | A | 0.00 | 8,624 | 0 | 8,624 | |
May 29 2012 | ARTC | ARTHROCARE CORP | Ahrens Christian | Director | Option Exercise | A | 0.00 | 4,312 | 0 | 4,312 | |
Mar 01 2012 | ARTC | ARTHROCARE CORP | SCHAFFNER SCOTT | SVP & GM SPORTS MED ... | Option Exercise | A | 33.39 | 10,137 | 338,474 | 10,137 | |
Mar 01 2012 | ARTC | ARTHROCARE CORP | SCHAFFNER SCOTT | SVP & GM SPORTS MED ... | Option Exercise | A | 26.49 | 42,529 | 1,126,593 | 42,529 | |
Mar 01 2012 | ARTC | ARTHROCARE CORP | SCHAFFNER SCOTT | SVP & GM SPORTS MED ... | Option Exercise | A | 26.24 | 8,460 | 221,990 | 8,460 | |
Mar 01 2012 | ARTC | ARTHROCARE CORP | SCHAFFNER SCOTT | SVP & GM SPORTS MED ... | Option Exercise | A | 33.39 | 2,617 | 87,382 | 2,617 | |
Mar 01 2012 | ARTC | ARTHROCARE CORP | SCHAFFNER SCOTT | SVP & GM SPORTS MED ... | Option Exercise | A | 26.49 | 12,471 | 330,357 | 12,471 | |
Mar 01 2012 | ARTC | ARTHROCARE CORP | SCHAFFNER SCOTT | SVP & GM SPORTS MED ... | Option Exercise | A | 26.24 | 3,484 | 91,420 | 3,484 | |
Mar 01 2012 | ARTC | ARTHROCARE CORP | SCHAFFNER SCOTT | SVP & GM SPORTS MED ... | Grant | A | 0.00 | 4,872 | 5 | 15,401 | 10.5 K to 15.4 K (+46.27 %) |
Mar 01 2012 | ARTC | ARTHROCARE CORP | SCHAFFNER SCOTT | SVP & GM SPORTS MED ... | Sell | D | 25.00 | 257 | 6,425 | 10,529 | 10.8 K to 10.5 K (-2.38 %) |
Mar 01 2012 | ARTC | ARTHROCARE CORP | SCHAFFNER SCOTT | SVP & GM SPORTS MED ... | Sell | D | 30.69 | 459 | 14,087 | 10,786 | 11.2 K to 10.8 K (-4.08 %) |
Mar 01 2012 | ARTC | ARTHROCARE CORP | SCHAFFNER SCOTT | SVP & GM SPORTS MED ... | Grant | A | 0.00 | 4,204 | 4 | 11,245 | 7 K to 11.2 K (+59.71 %) |
Mar 01 2012 | ARTC | ARTHROCARE CORP | SCHAFFNER SCOTT | SVP & GM SPORTS MED ... | Sell | D | 27.96 | 459 | 12,834 | 7,041 | 7.5 K to 7 K (-6.12 %) |
Mar 01 2012 | ARTC | ARTHROCARE CORP | SCHAFFNER SCOTT | SVP & GM SPORTS MED ... | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 0 to 7.5 K |
Mar 01 2012 | ARTC | ARTHROCARE CORP | Rew Richard W. II | Senior VP & General ... | Option Exercise | A | 26.24 | 8,186 | 214,801 | 8,186 | |
Mar 01 2012 | ARTC | ARTHROCARE CORP | Rew Richard W. II | Senior VP & General ... | Option Exercise | A | 26.24 | 3,373 | 88,508 | 3,373 | |
Mar 01 2012 | ARTC | ARTHROCARE CORP | Rew Richard W. II | Senior VP & General ... | Grant | A | 0.00 | 4,715 | 5 | 27,540 | 22.8 K to 27.5 K (+20.66 %) |
Mar 01 2012 | ARTC | ARTHROCARE CORP | Rew Richard W. II | Senior VP & General ... | Sell | D | 26.23 | 82 | 2,151 | 22,825 | 22.9 K to 22.8 K (-0.36 %) |
Mar 01 2012 | ARTC | ARTHROCARE CORP | Newton Todd | SVP, CFO & COO | Option Exercise | A | 26.24 | 19,379 | 508,505 | 19,379 | |
Mar 01 2012 | ARTC | ARTHROCARE CORP | Newton Todd | SVP, CFO & COO | Option Exercise | A | 26.24 | 3,806 | 99,869 | 3,806 | |
Mar 01 2012 | ARTC | ARTHROCARE CORP | Newton Todd | SVP, CFO & COO | Buy | P | 26.20 | 4,000 | 104,800 | 37,843 | 33.8 K to 37.8 K (+11.82 %) |
Mar 01 2012 | ARTC | ARTHROCARE CORP | Newton Todd | SVP, CFO & COO | Grant | A | 0.00 | 9,457 | 9 | 33,843 | 24.4 K to 33.8 K (+38.78 %) |
Mar 01 2012 | ARTC | ARTHROCARE CORP | FITZGERALD DAVID | Board of Directors | Option Exercise | A | 26.24 | 8,482 | 222,568 | 8,482 | |
Mar 01 2012 | ARTC | ARTHROCARE CORP | FITZGERALD DAVID | Board of Directors | Option Exercise | A | 26.24 | 3,701 | 97,114 | 3,701 | |
Mar 01 2012 | ARTC | ARTHROCARE CORP | FITZGERALD DAVID | Board of Directors | Grant | A | 0.00 | 37,000 | 37 | 139,559 | 102.6 K to 139.6 K (+36.08 %) |
Mar 01 2012 | ARTC | ARTHROCARE CORP | FITZGERALD DAVID | Board of Directors | Buy | P | 26.14 | 5,000 | 130,712 | 102,559 | 97.6 K to 102.6 K (+5.13 %) |
Mar 01 2012 | ARTC | ARTHROCARE CORP | Miclot Andrew | SVP & GM ENT Tech | Option Exercise | A | 33.39 | 9,228 | 308,123 | 9,228 | |
Mar 01 2012 | ARTC | ARTHROCARE CORP | Miclot Andrew | SVP & GM ENT Tech | Option Exercise | A | 26.24 | 8,459 | 221,964 | 8,459 | |
Mar 01 2012 | ARTC | ARTHROCARE CORP | Miclot Andrew | SVP & GM ENT Tech | Option Exercise | A | 23.50 | 32,980 | 775,030 | 32,980 | |
Mar 01 2012 | ARTC | ARTHROCARE CORP | Miclot Andrew | SVP & GM ENT Tech | Option Exercise | A | 33.39 | 3,526 | 117,733 | 3,526 | |
Mar 01 2012 | ARTC | ARTHROCARE CORP | Miclot Andrew | SVP & GM ENT Tech | Option Exercise | A | 26.24 | 3,485 | 91,446 | 3,485 | |
Mar 01 2012 | ARTC | ARTHROCARE CORP | Miclot Andrew | SVP & GM ENT Tech | Option Exercise | A | 23.50 | 17,020 | 399,970 | 17,020 | |
Mar 01 2012 | ARTC | ARTHROCARE CORP | Miclot Andrew | SVP & GM ENT Tech | Grant | A | 0.00 | 4,872 | 5 | 14,135 | 9.3 K to 14.1 K (+52.60 %) |
Mar 01 2012 | ARTC | ARTHROCARE CORP | Miclot Andrew | SVP & GM ENT Tech | Sell | D | 33.30 | 264 | 8,791 | 9,087 | 9.4 K to 9.1 K (-2.82 %) |
Mar 01 2012 | ARTC | ARTHROCARE CORP | Miclot Andrew | SVP & GM ENT Tech | Grant | A | 0.00 | 4,204 | 4 | 9,351 | 5.1 K to 9.4 K (+81.68 %) |
Mar 01 2012 | ARTC | ARTHROCARE CORP | Miclot Andrew | SVP & GM ENT Tech | Grant | A | 0.00 | 5,000 | 5 | 5,000 | 0 to 5 K |
Mar 01 2012 | ARTC | ARTHROCARE CORP | PACEK JAMES L | Sr VP, Strategic Bu ... | Option Exercise | A | 26.24 | 8,459 | 221,964 | 8,459 | |
Mar 01 2012 | ARTC | ARTHROCARE CORP | PACEK JAMES L | Sr VP, Strategic Bu ... | Option Exercise | A | 26.24 | 3,485 | 91,446 | 3,485 | |
Mar 01 2012 | ARTC | ARTHROCARE CORP | PACEK JAMES L | Sr VP, Strategic Bu ... | Grant | A | 0.00 | 4,872 | 5 | 22,553 | 17.7 K to 22.6 K (+27.56 %) |
Mar 01 2012 | ARTC | ARTHROCARE CORP | PACEK JAMES L | Sr VP, Strategic Bu ... | Sell | D | 26.23 | 59 | 1,548 | 17,681 | 17.7 K to 17.7 K (-0.33 %) |
Mar 01 2012 | ARTC | ARTHROCARE CORP | PACEK JAMES L | Sr VP, Strategic Bu ... | Sell | D | 25.00 | 309 | 7,725 | 17,740 | 18 K to 17.7 K (-1.71 %) |
Mar 01 2012 | ARTC | ARTHROCARE CORP | PACEK JAMES L | Sr VP, Strategic Bu ... | Sell | D | 25.56 | 772 | 19,732 | 18,049 | 18.8 K to 18 K (-4.10 %) |
Mar 01 2012 | ARTC | ARTHROCARE CORP | PACEK JAMES L | Sr VP, Strategic Bu ... | Sell | D | 35.25 | 155 | 5,464 | 21,321 | 21.5 K to 21.3 K (-0.72 %) |
Mar 01 2012 | ARTC | ARTHROCARE CORP | PACEK JAMES L | Sr VP, Strategic Bu ... | Sell | D | 33.62 | 59 | 1,984 | 21,476 | 21.5 K to 21.5 K (-0.27 %) |
Mar 01 2012 | ARTC | ARTHROCARE CORP | WOLOSZKO JEAN | CTO and SVP | Option Exercise | A | 26.24 | 3,738 | 98,085 | 110,039 | |
Mar 01 2012 | ARTC | ARTHROCARE CORP | WOLOSZKO JEAN | CTO and SVP | Option Exercise | A | 26.24 | 10,711 | 281,057 | 106,301 | |
Mar 01 2012 | ARTC | ARTHROCARE CORP | WOLOSZKO JEAN | CTO and SVP | Grant | A | 26.24 | 5,894 | 154,659 | 49,186 | 43.3 K to 49.2 K (+13.61 %) |
Mar 01 2012 | ARTC | ARTHROCARE CORP | PROTHRO BRUCE | Chief Regulatory Of ... | Option Exercise | A | 26.24 | 3,373 | 88,508 | 94,606 | |
Mar 01 2012 | ARTC | ARTHROCARE CORP | PROTHRO BRUCE | Chief Regulatory Of ... | Option Exercise | A | 26.24 | 8,186 | 214,801 | 91,233 | |
Mar 01 2012 | ARTC | ARTHROCARE CORP | PROTHRO BRUCE | Chief Regulatory Of ... | Grant | A | 0.00 | 4,715 | 5 | 29,773 | 25.1 K to 29.8 K (+18.82 %) |
Feb 09 2012 | ARTC | ARTHROCARE CORP | WOLOSZKO JEAN | CTO and SVP | Option Exercise | X | 31.50 | 2,969 | 93,524 | 92,621 | |
Feb 09 2012 | ARTC | ARTHROCARE CORP | WOLOSZKO JEAN | CTO and SVP | Option Exercise | X | 31.50 | 2,240 | 70,560 | 95,590 | |
Feb 09 2012 | ARTC | ARTHROCARE CORP | WOLOSZKO JEAN | CTO and SVP | Sell | S | 32.32 | 5,209 | 168,362 | 43,292 | 48.5 K to 43.3 K (-10.74 %) |